Luxbright Past Earnings Performance
Past criteria checks 0/6
Luxbright's earnings have been declining at an average annual rate of -18.3%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 67.7% per year.
Key information
-18.3%
Earnings growth rate
15.8%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 67.7% |
| Return on equity | -91.3% |
| Net Margin | -402.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Luxbright makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 6 | -22 | 24 | 0 |
| 31 Mar 24 | 3 | -24 | 23 | 0 |
| 31 Dec 23 | 1 | -25 | 22 | 0 |
| 30 Sep 23 | 1 | -24 | 21 | 0 |
| 30 Jun 23 | 0 | -23 | 21 | 0 |
| 31 Mar 23 | 1 | -22 | 21 | 0 |
| 31 Dec 22 | 1 | -21 | 21 | 0 |
| 30 Sep 22 | 1 | -20 | 20 | 0 |
| 30 Jun 22 | 1 | -20 | 20 | 0 |
| 31 Mar 22 | 1 | -19 | 20 | 0 |
| 31 Dec 21 | 1 | -18 | 20 | 0 |
| 30 Sep 21 | 1 | -17 | 19 | 0 |
| 30 Jun 21 | 1 | -16 | 18 | 0 |
| 31 Mar 21 | 1 | -14 | 16 | 0 |
| 31 Dec 20 | 1 | -12 | 15 | 0 |
| 30 Jun 20 | 3 | -11 | 6 | 0 |
| 31 Mar 20 | 2 | -11 | 6 | 0 |
| 31 Dec 19 | 2 | -11 | 7 | 0 |
| 31 Dec 18 | 1 | -12 | 9 | 0 |
| 31 Dec 17 | 1 | -7 | 13 | 0 |
| 31 Dec 16 | 1 | -3 | 6 | 0 |
Quality Earnings: LXB is currently unprofitable.
Growing Profit Margin: LXB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LXB is unprofitable, and losses have increased over the past 5 years at a rate of 18.3% per year.
Accelerating Growth: Unable to compare LXB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LXB is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).
Return on Equity
High ROE: LXB has a negative Return on Equity (-91.26%), as it is currently unprofitable.